Stockscreener 앱 받기
66.18
1.55%
-1.04
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
Is Exact Sciences Corporation stock cheap at current valuation2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Herriott James, Exact Sciences Corp SVP, sells $105k in stock By Investing.com - Investing.com Australia
Exact Sciences announces results from ALTUS study - TipRanks
Exact Sciences (EXAS) Is Up 6.3% After Oncoguard Liver Test Outperforms Ultrasound in ALTUS Study - Yahoo Finance
Exact Sciences' Blood Test Detects Liver Cancer Far Earlier Than Standard Ultrasound - Nasdaq
Exact Sciences Says Blood Test Beats Ultrasound for Quicker Liver Cancer Detection in Study - MarketScreener
EXAS Unveils Promising Results from ALTUS Study with Oncoguard L - GuruFocus
Exact Sciences’ liver cancer blood test shows superior early detection - Investing.com
Exact Sciences blood test shows improved liver cancer detection - StreetInsider
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test - Business Wire
Herriott James, Exact Sciences Corp SVP, sells $105k in stock - Investing.com Canada
Baranick, Exact Sciences EVP, sells $200k in EXAS stock - Investing.com
Exact Sciences (EXAS) Q3 2025 Earnings Transcript - AOL.com
Exact Sciences (EXAS) Gets a Hold from UBS - The Globe and Mail
Why Exact Sciences Corporation stock remains on buy listsWeekly Trend Recap & Weekly Consistent Profit Watchlists - fcp.pa.gov.br
How Exact Sciences Corporation stock performs in weak economy2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Why Exact Sciences Corporation stock could see breakout soonJuly 2025 Sector Moves & AI Driven Price Forecasts - fcp.pa.gov.br
Can Exact Sciences Corporation (EXK) stock stage a strong rebound this quarter - newser.com
Exact Sciences Corporation stock chart pattern explainedTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Leading vs lagging indicators on Exact Sciences Corporation performance2025 Analyst Calls & Risk Managed Investment Signals - newser.com
EXAS Stock Quote Price and Forecast - CNN
Key facts: Exact Sciences raises 2025 revenue forecast to $3.23B; Wells Fargo boosts price target to $85 - TradingView
Exact Sciences (NASDAQ:EXAS) Trading 8.1% Higher After Better-Than-Expected Earnings - MarketBeat
EXAS: Wells Fargo Raises Price Target to $85.00, Maintains Overw - GuruFocus
Is Exact Sciences Corporation stock a buy for dividend growthJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2025 Earnings Call Transcript - Insider Monkey
Exact Sciences to Participate in November 2025 Investor Conference - BioSpace
Exact Sciences Corp Faces Regulatory Risks Amid Potential Government Disruptions - TipRanks
Why Exact Sciences Stock Blasted Higher on Tuesday - The Motley Fool
Why Exact Sciences Stock Blasted Higher on Tuesday - Nasdaq
Exact Sciences Corp Reports Strong Q3 Earnings - TipRanks
Barclays Maintains Exact Sciences (EXAS) Overweight Recommendation - Nasdaq
Key facts: Exact Sciences Q3 Revenue Hits $850.7M; Cancerguard Launched; Analysts Raise Price Targets - TradingView
EXAS: TD Cowen Raises Price Target to $90 on Buy Rating | EXAS S - GuruFocus
Exact Sciences (EXAS) Receives Updated Analyst Rating from Baird - GuruFocus
EXAS: Benchmark Raises Price Target to $75 in Latest Analyst Rev - GuruFocus
EXAS: Guggenheim Raises Price Target to $75 While Maintaining Bu - GuruFocus
Stifel raises Exact Sciences stock price target to $80 on strong Cologuard growth - Investing.com Canada
EXAS: Barclays Raises Price Target to $77, Maintains Overweight Rating | EXAS Stock News - GuruFocus
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results - Benzinga
Madison-based Exact Sciences reports Q3 results topping analysts’ expectations - Wisconsin State Journal
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth - Yahoo! Finance Canada
EXAS: Stifel Raises Target Price to $80, Maintains Buy Rating | - GuruFocus
BTIG Raises Price Target for Exact Sciences (EXAS) to $85 | EXAS Stock News - GuruFocus
Exact Sciences stock price target raised to $85 from $75 at BTIG - Investing.com
Exact Sciences to Participate in November Investor Conference - Bluefield Daily Telegraph
Exact Sciences: Q3 Earnings Snapshot - theheraldreview.com
How Intuitive Surgical Stock Gained 19.5% Last Month - AOL.com
Canaccord Genuity raises Exact Sciences stock price target to $85 on strong growth - Investing.com
Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus
Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Exact Sciences Reports Record Q3 Revenue and Raises Guidance - TipRanks
Transcript : Exact Sciences Corporation, Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Exact Sciences Q3 2025 slides: 20% revenue growth, guidance raised - Investing.com
Earnings call transcript: Exact Sciences beats Q3 2025 EPS forecasts - Investing.com
Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
EXACT SCIENCES CORP SEC 10-Q Report - TradingView
1.69%
0.02%
자본화:
|
볼륨(24시간):